Skip to main content
Erschienen in: Intensive Care Medicine 6/2005

01.06.2005 | Experimental

Protective effect of β-glucan on lung injury after cecal ligation and puncture in rats

verfasst von: Hulya Babayigit, Can Kucuk, Erdogan Sozuer, Cevad Yazici, Kader Kose, Hulya Akgun

Erschienen in: Intensive Care Medicine | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Objective

Understanding the biological mediators involved in the complex inflammatory response of sepsis and acute lung injury offers the possibility of future investigations targeting treatment based on these mediators. This study investigated whether macrophage activator β-glucan has a protective effect on acute lung injury in an experimental model of sepsis.

Design and setting

Experimental study in an experimental research center.

Materials

30 rats randomized into three groups (sham, sepsis, and β-glucan).

Interventions

Cecal ligation and puncture were performed in the β-glucan and sepsis groups. The β-glucan group was given a single intraperitoneal dose of β-glucan (4 mg/kg) following cecal ligation.

Measurements and results

Rats treated with β-glucan had fewer circulating neutrophils, more blood monocytes, and higher serum interleukin 6 levels than septic animals. The percentages of neutrophils and lymphocytes from the bronchoalveolar lavage fluid and the myeloperoxidase activity measured in the lung tissue were lower in the β-glucan group than in the sepsis group. Less alveolar hemorrhage and neutrophil infiltration were observed in lungs from animals in the β-glucan group in the septic groups.

Conclusions

In this rat model of intra-abdominal sepsis β-glucan treatment partially protected against secondary lung injury, decreased lung hemorrhages, and lung neutrophilia. These results suggest that β-glucan protects against sepsis-associated lung damage.
Literatur
1.
Zurück zum Zitat Wickel DJ, Cheadle WG, Jones MA, Garrison RN (1997) Poor outcome from peritonitis is caused by disease peritoneal infection. Ann Surg 225:744–756 Wickel DJ, Cheadle WG, Jones MA, Garrison RN (1997) Poor outcome from peritonitis is caused by disease peritoneal infection. Ann Surg 225:744–756
2.
Zurück zum Zitat Poll T, Deventer SJH (1999) Cytokines and anti cytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13:413–427 Poll T, Deventer SJH (1999) Cytokines and anti cytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13:413–427
3.
Zurück zum Zitat Parker SJ, Watkins PE (2001) Experimental models of gram negative sepsis. Br J Surg 88:22–30CrossRefPubMed Parker SJ, Watkins PE (2001) Experimental models of gram negative sepsis. Br J Surg 88:22–30CrossRefPubMed
4.
Zurück zum Zitat Vincent JL (1997) New therapies in sepsis. Chest 112:330–338 Vincent JL (1997) New therapies in sepsis. Chest 112:330–338
5.
Zurück zum Zitat Sing B, Doane KJ, Niehaus GD (1998) Ultrastructural and cytochemical evaluation of sepsis-induced changes in the rat pulmonary intravascular mononuclear phagocytes. J Anat 192:13–23 Sing B, Doane KJ, Niehaus GD (1998) Ultrastructural and cytochemical evaluation of sepsis-induced changes in the rat pulmonary intravascular mononuclear phagocytes. J Anat 192:13–23
6.
Zurück zum Zitat Bedirli A, Gokahmetoglu S, Sakrak O, Ersoz N, Ayangil D, Esin H (2003) Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model. Am J Surg 185:339–343 Bedirli A, Gokahmetoglu S, Sakrak O, Ersoz N, Ayangil D, Esin H (2003) Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model. Am J Surg 185:339–343
7.
Zurück zum Zitat Mohaghegpur N, Dawson M, Hobbs P, Judd A, Winant R, Dousman L, Waldeck N, Hokama L, Tuse D, Kos F (1995) Glucans as immunological adjuvants. Adv Exp Med Biol 383:13–22 Mohaghegpur N, Dawson M, Hobbs P, Judd A, Winant R, Dousman L, Waldeck N, Hokama L, Tuse D, Kos F (1995) Glucans as immunological adjuvants. Adv Exp Med Biol 383:13–22
8.
Zurück zum Zitat Williams DL, Ha T, Li C, Kalbfleish JH, Laffan JJ, Ferguson DA (1999) Inhibiting early activation of tissue nuclear factor-B and nuclear factor interleukin 6 with (1>3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126:54–65 Williams DL, Ha T, Li C, Kalbfleish JH, Laffan JJ, Ferguson DA (1999) Inhibiting early activation of tissue nuclear factor-B and nuclear factor interleukin 6 with (1>3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126:54–65
9.
Zurück zum Zitat Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock-A review of laboratory models and proposal. J Surg Res 29:189–201 Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock-A review of laboratory models and proposal. J Surg Res 29:189–201
10.
Zurück zum Zitat Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209 Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209
11.
Zurück zum Zitat King J, Deboisblanc BP, Mason CM, Onofrio JM, Lipscomb G, Mercante DE, Summer WR, Nelson S (1995) Effect of granulocyte colony stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 151:302–309 King J, Deboisblanc BP, Mason CM, Onofrio JM, Lipscomb G, Mercante DE, Summer WR, Nelson S (1995) Effect of granulocyte colony stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 151:302–309
12.
Zurück zum Zitat Sessler CN, Blommfield GL, Fowler AA (1996) Current concept of sepsis and acute lung injury. Clin Chest Med 17:223–235 Sessler CN, Blommfield GL, Fowler AA (1996) Current concept of sepsis and acute lung injury. Clin Chest Med 17:223–235
13.
Zurück zum Zitat Almdahl SM, Bogwald J, Hoffman J, Seljelid R (1987) Treatment of experimental peritonitis in rats by transfer of peritoneal mononuclear cell from rats by transfer of peritoneal mononuclear cell from rats injected with semisoluble aminated glucan. Acta Chir Scand 153:535–539 Almdahl SM, Bogwald J, Hoffman J, Seljelid R (1987) Treatment of experimental peritonitis in rats by transfer of peritoneal mononuclear cell from rats by transfer of peritoneal mononuclear cell from rats injected with semisoluble aminated glucan. Acta Chir Scand 153:535–539
14.
Zurück zum Zitat Liang J, Melican D, Cafro L, Palace G, Fisette L, Armstrong R, Patchen ML (1998) Enhanced clearance of a multiple antibiotic resistant staphylococcus aureus in rats treated with PGG glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 20:595–614 Liang J, Melican D, Cafro L, Palace G, Fisette L, Armstrong R, Patchen ML (1998) Enhanced clearance of a multiple antibiotic resistant staphylococcus aureus in rats treated with PGG glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 20:595–614
15.
Zurück zum Zitat Williams DL, Mueller A, Browder W (1995) Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae. J Endotoxin Res 2:203–208 Williams DL, Mueller A, Browder W (1995) Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae. J Endotoxin Res 2:203–208
16.
Zurück zum Zitat Williams DL, Ha T, Li C, Kalbfleish JH, Schweitzer J, Vogt W, Browder IW (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 31:1808–1818 Williams DL, Ha T, Li C, Kalbfleish JH, Schweitzer J, Vogt W, Browder IW (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 31:1808–1818
17.
Zurück zum Zitat Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P (1994) A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high surgical patients. Arch Surg 129:1204–1210 Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P (1994) A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high surgical patients. Arch Surg 129:1204–1210
18.
Zurück zum Zitat Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE (1999) Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Arch Surg 134:977–983 Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE (1999) Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Arch Surg 134:977–983
19.
Zurück zum Zitat Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB (2004) Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 172:449–456 Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB (2004) Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 172:449–456
20.
Zurück zum Zitat Schmekel B, Karlsson SE, Linden M, Sundstrom C, Tegner H, Venge P (1990) Myeloperoxidase in human lung lavage. A marker of local neutrophil activity. Inflammation 14:445–447 Schmekel B, Karlsson SE, Linden M, Sundstrom C, Tegner H, Venge P (1990) Myeloperoxidase in human lung lavage. A marker of local neutrophil activity. Inflammation 14:445–447
21.
Zurück zum Zitat Griswold J, Maier RV (1988) Neutrophil phagocytosis, during endotoxin-induced lung injury. J Surg Res 44:417–424 Griswold J, Maier RV (1988) Neutrophil phagocytosis, during endotoxin-induced lung injury. J Surg Res 44:417–424
22.
Zurück zum Zitat Lazaron V, Barke A (1999) Gram-negative bacterial sepsis and the sepsis syndrome. Urol Clin North Am 26:687–699 Lazaron V, Barke A (1999) Gram-negative bacterial sepsis and the sepsis syndrome. Urol Clin North Am 26:687–699
23.
Zurück zum Zitat Modig J, Samuelsson T, Hallgren R (1986) The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation 14:121–134 Modig J, Samuelsson T, Hallgren R (1986) The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation 14:121–134
24.
Zurück zum Zitat Akira S, Kishimoto T (1996) Role of interleukin-6 in macrophage function. Curr Opin Hematol 3:87–93 Akira S, Kishimoto T (1996) Role of interleukin-6 in macrophage function. Curr Opin Hematol 3:87–93
25.
Zurück zum Zitat Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43–58 Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43–58
26.
Zurück zum Zitat Blacwell TS, Christman JW (1996) Sepsis and cytokines: current status. Br J Anaesth 77:110–117PubMed Blacwell TS, Christman JW (1996) Sepsis and cytokines: current status. Br J Anaesth 77:110–117PubMed
27.
Zurück zum Zitat Masih NK, Madaj K, Hintelmann H, Gast G, Kaneko Y (1997) Down-regulation of tumor necrosis factor a moderato reduction of interleukin-1β but not interleukin-6 or interleukin-10 by glucan immunomodulators curdlan sulfate and lentinen. Int J Immunopharmacol 19:463–468 Masih NK, Madaj K, Hintelmann H, Gast G, Kaneko Y (1997) Down-regulation of tumor necrosis factor a moderato reduction of interleukin-1β but not interleukin-6 or interleukin-10 by glucan immunomodulators curdlan sulfate and lentinen. Int J Immunopharmacol 19:463–468
28.
Zurück zum Zitat Rasmussen LT, Seljelid R (1991) Novel immunomodulators with pronounced in vivo effect caused by stimulation of cytokine release. J Cell Biochem 46:60–68 Rasmussen LT, Seljelid R (1991) Novel immunomodulators with pronounced in vivo effect caused by stimulation of cytokine release. J Cell Biochem 46:60–68
29.
Zurück zum Zitat Tokunaka K, Ohno N, Adachi Y, Tanaka S, Tamura H, Yadomae T (2000) Immunopharmacological and immunotoxicological activities of a water-soluble (1>3)- β-D-glucan, CSBG from Candida spp. Int J Immunopharmacol 22:383–394 Tokunaka K, Ohno N, Adachi Y, Tanaka S, Tamura H, Yadomae T (2000) Immunopharmacological and immunotoxicological activities of a water-soluble (1>3)- β-D-glucan, CSBG from Candida spp. Int J Immunopharmacol 22:383–394
30.
Zurück zum Zitat Yin K, Wilmenski J, Wang CQ, Thamont M (2000) Lung compartmentalization of inflammatory cell in sepsis. Inflammation 24:543–557 Yin K, Wilmenski J, Wang CQ, Thamont M (2000) Lung compartmentalization of inflammatory cell in sepsis. Inflammation 24:543–557
31.
Zurück zum Zitat Czermak BJ, Breckwoldt M, Ravage ZB, Huber-Lang M, Schmal H, Bless NM, Friedl HP, Ward PA (1999) Mechanisms of enhanced lung injury during sepsis. Am J Pathol 154:1057–1065 Czermak BJ, Breckwoldt M, Ravage ZB, Huber-Lang M, Schmal H, Bless NM, Friedl HP, Ward PA (1999) Mechanisms of enhanced lung injury during sepsis. Am J Pathol 154:1057–1065
Metadaten
Titel
Protective effect of β-glucan on lung injury after cecal ligation and puncture in rats
verfasst von
Hulya Babayigit
Can Kucuk
Erdogan Sozuer
Cevad Yazici
Kader Kose
Hulya Akgun
Publikationsdatum
01.06.2005
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 6/2005
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-2629-x

Weitere Artikel der Ausgabe 6/2005

Intensive Care Medicine 6/2005 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.